Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized Multicenter Study of Induction With or Without Granulocyte Colony-Stimulating Factor in AML

NCT00820976 is registered in ClinicalTrials.gov with Turkish Leukemia Study Group as lead sponsor.

NCT NCT00820976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00820976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized Multicenter Study of Induction With or Without Granulocyte Colony-Stimulating Factor in AML
Lead sponsor
Turkish Leukemia Study Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1996
Completion date
January 31, 2009
Enrollment
260 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aml